A randomized controlled trial on radiofrequency ablation using variable and fixed electrodes for the treatment of malignant hepatic tumors
Not Applicable
- Conditions
- malignant hepatic tumors
- Registration Number
- JPRN-UMIN000032072
- Lead Sponsor
- Juntendo University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 210
Inclusion Criteria
Not provided
Exclusion Criteria
(i) tumor not visualized by ultrasonography or not accessible percutaneously (ii) total bilirubin level of 3.0 mg/dl or higher (iii) platelet count of less than 50x10 9/l or prothrombin activity of less than 50% (iv) refractory ascites (v) enterobiliary reflux
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary endpoints are the incidence of adverse events and the short-term treatment response based on contrast-CT using the modified RECIST criteria following one session of radiofrequency ablation.
- Secondary Outcome Measures
Name Time Method